Ameritas Investment Partners, Inc. Alector, Inc. Transaction History
Ameritas Investment Partners, Inc.
- $2.98 Billion
- Q4 2024
A detailed history of Ameritas Investment Partners, Inc. transactions in Alector, Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 8,175 shares of ALEC stock, worth $13,407. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,175
Previous 8,175
-0.0%
Holding current value
$13,407
Previous $38,000
60.53%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ALEC
# of Institutions
155Shares Held
55MCall Options Held
39.7KPut Options Held
51K-
Ra Capital Management, L.P. Boston, MA9.7MShares$15.9 Million0.3% of portfolio
-
Black Rock Inc. New York, NY9.1MShares$14.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.62MShares$9.21 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.91MShares$3.14 Million0.0% of portfolio
-
State Street Corp Boston, MA1.85MShares$3.03 Million0.0% of portfolio
About Alector, Inc.
- Ticker ALEC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,563,904
- Market Cap $135M
- Description
- Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...